Cargando…
PRM-MS Quantitative Analysis of Isomeric N-Glycopeptides Derived from Human Serum Haptoglobin of Patients with Cirrhosis and Hepatocellular Carcinoma
Currently, surveillance strategies have inadequate performance for cirrhosis and early detection of hepatocellular carcinoma (HCC). The glycosylation of serum haptoglobin has shown to have significant differences between cirrhosis and HCC, thus can be used for diagnosis. We performed a comprehensive...
Autores principales: | Gutierrez Reyes, Cristian D., Huang, Yifan, Atashi, Mojgan, Zhang, Jie, Zhu, Jianhui, Liu, Suyu, Parikh, Neehar D., Singal, Amit G., Dai, Jianliang, Lubman, David M., Mechref, Yehia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400780/ https://www.ncbi.nlm.nih.gov/pubmed/34436504 http://dx.doi.org/10.3390/metabo11080563 |
Ejemplares similares
-
Discovery of Core-Fucosylated Glycopeptides as Diagnostic
Biomarkers for Early HCC in Patients with NASH Cirrhosis Using LC-HCD-PRM-MS/MS
por: Tan, Yifei, et al.
Publicado: (2023) -
Glycopeptides with Sialyl Lewis Antigen in Serum Haptoglobin
as Candidate Biomarkers for Nonalcoholic Steatohepatitis Hepatocellular
Carcinoma Using a Higher-Energy Collision-Induced Dissociation Parallel
Reaction Monitoring-Mass Spectrometry Method
por: Lin, Yu, et al.
Publicado: (2022) -
A Fucosylated Glycopeptide as a Candidate Biomarker for Early Diagnosis of NASH Hepatocellular Carcinoma Using a Stepped HCD Method and PRM Evaluation
por: Lin, Yu, et al.
Publicado: (2022) -
LC-MS/MS Isomeric Profiling of N-Glycans Derived from Low-Abundant Serum Glycoproteins in Mild Cognitive Impairment Patients
por: Reyes, Cristian D. Gutierrez, et al.
Publicado: (2022) -
Large Scale Screening and Quantitative Analysis of Site-Specific N-Glycopeptides from Human Serum in Early Alzheimer’s Disease Using LC-HCD-PRM-MS
por: Pan, Lingyun, et al.
Publicado: (2022)